BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18797861)

  • 1. Molecular structure of low density lipoprotein: current status and future challenges.
    Prassl R; Laggner P
    Eur Biophys J; 2009 Feb; 38(2):145-58. PubMed ID: 18797861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical model of human apolipoprotein B100 tertiary structure.
    Krisko A; Etchebest C
    Proteins; 2007 Feb; 66(2):342-58. PubMed ID: 17109403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural changes induced by acidic pH in human apolipoprotein B-100.
    Fernández-Higuero JA; Benito-Vicente A; Etxebarria A; Milicua JC; Ostolaza H; Arrondo JL; Martín C
    Sci Rep; 2016 Nov; 6():36324. PubMed ID: 27824107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B and low-density lipoprotein structure: implications for biosynthesis of triglyceride-rich lipoproteins.
    Schumaker VN; Phillips ML; Chatterton JE
    Adv Protein Chem; 1994; 45():205-48. PubMed ID: 8154370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
    Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K
    Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles.
    Garner B; Harvey DJ; Royle L; Frischmann M; Nigon F; Chapman MJ; Rudd PM
    Glycobiology; 2001 Oct; 11(10):791-802. PubMed ID: 11588155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.
    Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.
    Fernández-Higuero JA; Etxebarria A; Benito-Vicente A; Alves AC; Arrondo JL; Ostolaza H; Bourbon M; Martin C
    Sci Rep; 2015 Dec; 5():18184. PubMed ID: 26643808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
    J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
    Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
    Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
    Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conversion of apoB100 low density lipoprotein/high density lipoprotein particles to apoB100 very low density lipoproteins in response to oleic acid occurs in the endoplasmic reticulum and not in the Golgi in McA RH7777 cells.
    Yamaguchi J; Gamble MV; Conlon D; Liang JS; Ginsberg HN
    J Biol Chem; 2003 Oct; 278(43):42643-51. PubMed ID: 12917397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low density lipoprotein (LDL)-antioxidant flavonoids from roots of Sophora flavescens.
    Jeong TS; Ryu YB; Kim HY; Curtis-Long MJ; An S; Lee JH; Lee WS; Park KH
    Biol Pharm Bull; 2008 Nov; 31(11):2097-102. PubMed ID: 18981580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charged amino acid residues 997-1000 of human apolipoprotein B100 are critical for the initiation of lipoprotein assembly and the formation of a stable lipidated primordial particle in McA-RH7777 cells.
    Manchekar M; Richardson PE; Sun Z; Liu Y; Segrest JP; Dashti N
    J Biol Chem; 2008 Oct; 283(43):29251-65. PubMed ID: 18725409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.
    Le Bloc'h J; Leray V; Chetiveaux M; Freuchet B; Magot T; Krempf M; Nguyen P; Ouguerram K
    J Pharmacol Exp Ther; 2010 Aug; 334(2):583-9. PubMed ID: 20442223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-electron microscopy of low density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moiety.
    van Antwerpen R; Chen GC; Pullinger CR; Kane JP; LaBelle M; Krauss RM; Luna-Chavez C; Forte TM; Gilkey JC
    J Lipid Res; 1997 Apr; 38(4):659-69. PubMed ID: 9144081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and functional properties of in vitro oxidized low density lipoprotein.
    Harduin P; Tailleux A; Lestavel S; Clavey V; Fruchart JC; Fievet C
    J Lipid Res; 1995 May; 36(5):919-30. PubMed ID: 7658164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
    J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.